
Viatris Faces $400M Supply Hit But Advances Innovation Pipeline
Viatris Inc.Description
What this story covers
Viatris reported Q3 revenues of $3.76B, flat amid $100M Indore facility impact, with nine-month net loss of $3.17B driven by $2.94B goodwill impairment. Strategic acquisitions like Idorsia assets bolster pipeline, while divestitures streamline operations. Segments show mixed results, with Greater China up 10%. Liquidity strong at $1.5B ops cash, focusing on deleveraging and R&D. Risks from tariffs and supply persist.
Story snapshot
CompanyViatris Inc.
TickerVTRS
VariantStandard detailed
Duration16:47
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001792044-25-000046
Full Story Script
Content not available for this story.